Contact

Bryan Hughes

Managing Director

Bryan Hughes is a Managing Director of PMCF and leads the firm’s Healthcare team. In addition to leading this team, he also assists the firms’ transactional needs within the business services & technology and consumer, food, & retail sectors. He has more than 20 years of industry experience advising clients with mergers and acquisitions, leveraged buyouts, private placements, financings, valuation, and strategic consulting. From large global companies to small, privately-held businesses, Bryan’s clients include contract manufacturers, life sciences companies, diagnostics businesses, drug delivery services, laboratories, and medical device manufacturers. He has completed over 30 transactions with a combined deal value totaling more than $5 billion.

Bryan began his career at PMCF as an Analyst. Over his tenure at the firm, he was promoted several times, advancing to his current role as Managing Director. Bryan has written numerous articles for healthcare and medical technology industry publications. He is a frequent speaker at business, media, and industry organization events, sharing his insight of various investment banking topics, such as M&A and macro trends within the medical manufacturing and healthcare industries.

Bryan earned a BBA with an emphasis in finance from the Stephen M. Ross School of Business at the University of Michigan. He is a licensed securities representative holding his Series 7 and 63 registrations.

Transaction Experience

PMCF Advises CLM Enterprises, Inc. on its Sale to an Employee Stock Ownership Plan

Healthcare, Healthcare Services, Medical Technology
leading franchisee of
has been acquired by

PMCF Advises Raland Compliance Partners in its Sale to Akkodis, A Global Digital Engineering Company and Part of The Adecco Group

Business Services, Healthcare
has been acquired by
a portfolio company of

PMCF Advises The Partner Companies, LLC in its Acquisition of UPG Company, LLC

Industrial Manufacturing, Plastics, Plastics & Packaging
has acquired
an affiliate of

PMCF Advises Eagle Pharmacy in its Sale to J. Knipper and Company

Healthcare, Healthcare Services, Private Equity & Financial Sponsor Coverage
has been acquired by
a portfolio company of

PMCF Advises Rhythmlink International, LLC In Its Sale Transaction To New Heritage Capital

Healthcare, Medical Technology
has been acquired by

PMCF advises Wright & Filippis in the sale of its Specialty Seating and Mobility division to National Seating & Mobility

Healthcare, Healthcare Services
has been acquired by
a portfolio company of

PMCF advises Respiratory Technologies, Inc. in its sale transaction to Royal Philips

Healthcare, Medical Technology, Private Equity & Financial Sponsor Coverage
a portfolio company of
has been acquired by

PMCF advises Mountainside Medical in its sale transaction to Tecomet Inc.

Healthcare, Medical Technology
has been acquired by
a portfolio company of

Publications

Medtech is entering 2026 with a healthier M&A environment supported by improved financing conditions, resilient sector performance, and a more straightforward path for strategic buyers and private equity.

Read More

M&A activity in the Medical Technology sector remained subdued in Q3 2025 at 102 announced transactions, significantly below the 165 deals recorded in Q3 2024.

Read More

Tariffs and staffing stability remain key factors shaping healthcare and MedTech M&A in 2025.

Read More

M&A activity in the Medical Technology sector remained subdued in Q2 2025, with 104 announced transactions, a decline from the 128 deals recorded in Q2 2024.

Read More

Capital continues to flow into MedTech M&A as companies pursue AI-driven solutions to streamline administrative tasks and drive improved patient outcomes.

Read More